Search

everythinglearnresearchcommunity

for

Search:↓

Oclacitinib effectively treated a diabetic cat's severe skin issues without raising glucose levels, and surgery fixed eyelid fusion.

Paljeong-san pharmacopuncture helps reduce symptoms of enlarged prostate by slowing tissue growth.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Blocking the Hedgehog pathway may help overcome drug resistance in multiple myeloma.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Alpha mangostin may protect certain breast cancer cells by activating the p53 pathway.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Oral Janus kinase inhibitors may be an effective treatment option for lichen planopilaris with some risk of increased cholesterol and liver enzyme levels.

Some side effects of breast cancer chemotherapy last longer than others, and patient feedback can help improve care.

Upadacitinib may effectively treat both alopecia universalis and Crohn's disease.

Patients with alopecia areata face challenges accessing Janus kinase inhibitors, but some see positive results.

The zinc-coordinated nanogel therapy speeds up wound healing after pancreas surgery by balancing metabolism and fighting bacteria.

Cold Atmospheric Plasma shows promise in treating aggressive breast cancer by targeting cancer cells while sparing normal tissue.

Marine compounds from gorgonians and soft corals show promise for drug development, especially for chronic disorders.

Plant-derived nanovesicles show promise in cancer treatment but need standardized preparation.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Cancer treatments often cause skin, nail, and hair problems.

Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.

The new drug carriers show promise for better targeting and treating ovarian cancer.

Using finasteride and doxazosina together works better for treating benign prostatic hyperplasia than using just one.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Lasers can help reduce skin side effects from cancer treatment.